» Articles » PMID: 15705867

Polymorphisms in DNA Base Excision Repair Genes ADPRT and XRCC1 and Risk of Lung Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2005 Feb 12
PMID 15705867
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine diphosphate ribosyl transferase (ADPRT) and X-ray repair cross-complementing 1 (XRCC1) are two major DNA base excision repair (BER) proteins and act interactively in stimulating and executing BER processes. Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Gln have been associated with altered protein function and BER activity. This case-control study examined the contribution of these two polymorphisms, alone and in combination, or in interaction with smoking, to the risk of developing lung cancer. We estimated the risk of lung cancer associated with these polymorphisms in 1,000 cases and 1,000 cancer-free controls using logistic regression models. Subjects having the ADPRT Ala/Ala genotype had an odds ratio (OR) of 1.68 [95% confidence interval (95% CI), 1.27-2.23] compared with those having the Val/Val genotype. A greater than multiplicative joint effect between the ADPRT polymorphism and smoking was observed. The ORs (95% CI) of the Ala/Ala genotype for nonsmokers and smokers who smoked < or =16, 16 to 28, or >28 pack-years were 1.13 (0.79-1.62), 1.35 (0.68-2.70), 2.46 (1.35-4.51) or 17.09 (8.15-35.83), respectively (P trend test < 0.001). Gene-gene interaction of ADPRT and XRCC1 polymorphisms increased risk of lung cancer in a supermultiplicative manner (OR for the presence of both ADPRT 762Ala/Ala and XRCC1 399Gln/Gln genotypes, 5.91; 95% CI, 2.09-16.72), although the XRCC1 polymorphism itself was not associated with the risk. In conclusion, the ADPRT Val762Ala polymorphism plays an important role in smoking-related lung cancer and the XRCC1 Arg399Gln polymorphism may serve as a risk modifier.

Citing Articles

Associations between polymorphisms in genes of base excision repair pathway and lung cancer risk.

Liu S, Xiao Y, Hu C, Li M Transl Cancer Res. 2022; 9(4):2780-2800.

PMID: 35117636 PMC: 8799111. DOI: 10.21037/tcr.2020.02.44.


rs1136410 Val762Ala contributes to an increased risk of overall cancer in the East Asian population: a meta-analysis.

Xin Y, Yang L, Su M, Cheng X, Zhu L, Liu J J Int Med Res. 2021; 49(3):300060521992956.

PMID: 33706586 PMC: 8168028. DOI: 10.1177/0300060521992956.


Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes.

Jin J, Robeson H, Fagan P, Orloff M PLoS One. 2020; 15(12):e0243509.

PMID: 33284833 PMC: 7721167. DOI: 10.1371/journal.pone.0243509.


Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma.

Avitabile M, Lasorsa V, Cantalupo S, Cardinale A, Cimmino F, Montella A J Cell Mol Med. 2020; 24(7):4072-4081.

PMID: 32103589 PMC: 7171401. DOI: 10.1111/jcmm.15058.


gene polymorphisms and neuroblastoma susceptibility in Chinese children.

Cheng J, Zhuo Z, Zhao P, Zhu J, Xin Y, Zhang J J Cancer. 2019; 10(18):4159-4164.

PMID: 31413734 PMC: 6691706. DOI: 10.7150/jca.34222.